With an agreed success rate of about 85 per cent.
the role of oral oxytetracycline hydrochloride in the treatment of non-specific urethritis was firmly established a decade ago. Other oral tetracyclines have proved of similar value.
While the results obtained with intramuscular oxytetracycline and other tetracyclines have been comparable, the incidence of pain at the injection site has been such that this form of administration could not be recommended for routine use (Morton, 1961) .
Intramuscular medication avoids gastrointestinal side-effects, eliminates sharing of treatment with a consort, and gives proof that treatment has been taken. Rolitetracycine nitrate has advantages over former tetracyclines in that it is said to cause significantly less pain on injection, is more efficiently absorbed, and produces and maintains adequate blood levels for 24 hours after a single intramuscular injection. It December 16, 1967. previous non-specific urethritis and in eleven there had been previous gonorrhoea. The incubation period was 10 days or less in four cases, over 10 days in seventeen, and unknown or doubtful in 24. In all but seven cases the duration of the discharge was less than 10 days. In most men the urethritis was well marked, the discharge being purulent in ten and muco-purulent in 27. In five the two-glass urine test showed a haze of pus in both glasses and in nineteen there was a haze in the first glass only; seven patients were unable to provide a sample. Reiter's disease was present in one patient.
Gonorrhoea was excluded by negative results to Gram-stained smears and cultures of the urethral discharge, and infestation by Trichomonas vaginalis was excluded by negative results to wet smears and cultures.
Wassermann reaction and Kahn and Reiter protein complement-fixation tests were carried out in all cases.
Management
The patients were instructed to attend for daily injections of rolitetracycline nitrate for 4 consecutive days. The routine dosage was 350 mg. per injection and all injections were given in the upper and outer quadrant of the buttock. The aim of follow-up was to see the patient on three occasions during the 2 weeks following completion of therapy and thereafter at increasingly longer intervals for up to 3 months.
Results
Of the 45 patients treated, 42 completed the schedule as prescribed. One patiefnt defaulted after three injections but he had no complaint of adverse reactions. Two patients complained of systemic side-effects; one stated that 15 minutes after his first injection he had had an attack of nausea, sweating, and palpitation, and the other developed headache, vomiting, and pyrexia. Ten patients complained of pain, aching, or stiffness at the injection site; discomfort lasted on average about an hour after at least one of the injections but one man complained of discomfort lasting for a week. In none of these cases was the complaint of such severity as to warrant interruption of the routine. There were no gastrointestinal side-effects.
Follow-up rates among the 42 patients who completed the schedule of treatment were as follows:
One patient defaulted immediately; 41 (98 per cent.) were followed for up to one week or more. 37 (88 per cent.) were followed for 1 week or more. 33 (78 per cent.) were followed for 2 weeks or more. 20 (47 per cent.) were followed for 9 weeks or more.
Judged by the cessation of the urethral discharge and the presence of a clear urine, the treatment was successful in 37 of the 42 cases (88 per cent.). In six (16 per cent.) of these 37 cases there was a late recurrence of non-specific urethritis.
Discussion
The satisfactory response in 37 of 42 cases was comparable with the best results obtained from oral tetracyclines as reported by other workers. The degree of discomfort caused by the injection was much less than that observed by one of us (R. S. Morton) using oxytetracycline hydrochloride intramuscularly when fourteen of 48 men complained and seven had to be withdrawn from the trial (Morton, 1961 
